FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk

[Joe]

Manufacturer calls Evista a valuable tool, but critics say itsheart risks outweigh benefits

More... (http://www.healthcentral.com/breast-cancer/news-160230-31.html)